Scholpa Natalie E, Simmons Epiphani C, Snider Justin M, Barrett Kelsey, Buss Lauren G, Schnellmann Rick G
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Southern Arizona VA Health Care System, Tucson, Arizona, USA.
J Neurotrauma. 2025 Feb;42(3-4):182-196. doi: 10.1089/neu.2024.0385. Epub 2024 Dec 17.
Following spinal cord injury (SCI), there is a short-lived recovery phase that ultimately plateaus. Understanding changes within the spinal cord over time may facilitate targeted approaches to prevent and/or reverse this plateau and allow for continued recovery. Untargeted metabolomics revealed distinct metabolic profiles within the injured cord during recovery (7 days postinjury [DPI]) and plateau (21 DPI) periods in a mouse model of severe contusion SCI. Alterations in lipid metabolites, particularly those involved in phospholipid (PL) metabolism, largely contributed to overall differences. PLs are hydrolyzed by phospholipases A2 (PLA2s), yielding lysophospholipids (LPLs) and fatty acids (FAs). PL metabolites decreased between 7 and 21 DPI, whereas LPLs increased at 21 DPI, suggesting amplified PL metabolism during the plateau phase. Expression of various PLA2s also differed between the two time points, further supporting dysregulation of PL metabolism during the two phases of injury. FAs, which can promote inflammation, mitochondrial dysfunction, and neuronal damage, were increased regardless of time point. Carnitine can bind with FAs to form acylcarnitines, lessening FA-induced toxicity. In contrast to FAs, carnitine and acylcarnitines were increased at 7 DPI, but decreased at 21 DPI, suggesting a loss of carnitine-mediated mitigation of FA toxicity at the later time point, which may contribute to the cessation of recovery post-SCI. Alterations in oxidative phosphorylation and tricarboxylic acid cycle metabolites were also observed, indicating persistent although dissimilar disruptions in mitochondrial function. These data aid in increasing our understanding of lipid metabolism following SCI and have the potential to lead to new biomarkers and/or therapeutic strategies.
脊髓损伤(SCI)后,会有一个短暂的恢复阶段,最终会进入平台期。了解脊髓随时间的变化可能有助于采取针对性的方法来预防和/或逆转这种平台期,并实现持续恢复。在严重挫伤性SCI小鼠模型中,非靶向代谢组学揭示了恢复阶段(损伤后7天[DPI])和平台期(21 DPI)损伤脊髓内不同的代谢谱。脂质代谢物的改变,尤其是那些参与磷脂(PL)代谢的代谢物,在很大程度上导致了整体差异。PLs被磷脂酶A2(PLA2s)水解,产生溶血磷脂(LPLs)和脂肪酸(FAs)。PL代谢物在7至21 DPI之间减少,而LPLs在21 DPI时增加,这表明平台期PL代谢增强。两个时间点各种PLA2s的表达也不同,进一步支持了损伤两个阶段PL代谢的失调。无论时间点如何,可促进炎症、线粒体功能障碍和神经元损伤的FAs均增加。肉碱可与FAs结合形成酰基肉碱,减轻FA诱导的毒性。与FAs相反,肉碱和酰基肉碱在7 DPI时增加,但在21 DPI时减少,这表明在后期肉碱介导的FA毒性减轻作用丧失,这可能导致SCI后恢复停止。还观察到氧化磷酸化和三羧酸循环代谢物的改变,表明线粒体功能存在持续但不同的破坏。这些数据有助于增进我们对SCI后脂质代谢的理解,并有可能带来新的生物标志物和/或治疗策略。